Pharma Company Still Hasn't Reversed 5,000% Price Hike
Even though Martin Shkreli said they would backtrack
By Evann Gastaldo,  Newser Staff
Posted Oct 7, 2015 2:00 PM CDT
Activists hold signs with the image of Turing Pharmaceuticals CEO Martin Shkreli in front the building that houses Turing's offices, in New York, Oct. 1, 2015, during a protest highlighting drug pricing.   (AP Photo/Craig Ruttle)

(Newser) – Two weeks ago, Martin Shkreli, the controversial CEO of Turing Pharmaceuticals, said that, following much public pressure, he would dial back his company's 5,000% price hike on a toxoplasmosis drug. But Daraprim, which jumped from $13.50 to $750 per pill, still costs the same amount, Business Insider's Lydia Ramsey reports after checking it out at her local pharmacy. (In fact, thanks to pharmacy fees, she would actually be paying about $900 per pill.) In contrast, another drug company that came under fire for a similar price hike almost immediately lowered its price, Ramsey notes. Turing did not respond to questions about Daraprim's current price.